Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
29
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lee Phillip E | Chief Financial Officer | 21 | $0 | $0 | 2033-03-17 |
| Bono Raquel C. | Director | 2 | $0 | $0 | 2026-10-16 |
| Finney Kevin | Director | 12 | $61.9K | $0 | 2026-07-16 |
| Wheadon David E. | Director | 11 | $0 | $0 | 2026-07-16 |
| Watson W. Mark | Director | 16 | $47.6K | $0 | 2026-07-16 |
| BREITMEYER JAMES B | Director | 4 | $0 | $0 | 2026-07-16 |
| HERON ELAINE J | Director | 12 | $15.9K | $0 | 2026-07-16 |
| Grasman Jeroen Nicolaas | Chief Financial Officer | 5 | $0 | $0 | 2026-05-19 |
| Cummings James F. | Chief Medical Officer | 25 | $0 | $0 | 2026-03-28 |
| Tucker Sean | SVP, Chief Scientific Officer | 52 | $60.0K | $102.0K | 2026-03-28 |
| Berg Edward B | SVP, General Counsel | 20 | $0 | $0 | 2026-03-24 |
| Lo Steven | President, Chief Exec Officer | 12 | $49.0K | $0 | 2026-03-24 |
| Finney Michael J. | Director | 28 | $417.0K | $0 | 2025-06-13 |
| Yedid Robert A. | Director | 25 | $0 | $95.1K | 2024-06-11 |
| Floroiu Cezar Andrei | President, Chief Exec Officer | 11 | $0 | $0 | 2023-03-17 |
| Cherrington Julie M | Director | 3 | $0 | $0 | 2022-08-04 |
| Davis Todd C | Director | 8 | $0 | $196.8K | 2022-08-04 |
| Ahmad Fuad | Interim CFO | 1 | $16.1K | $0 | 2022-06-22 |
| Echerd Margaret | VP, Corporate Controller, PAO | 33 | $0 | $472.5K | 2021-11-30 |
| WILSON KAREN J | Director | 2 | $0 | $0 | 2021-06-16 |
| Latour Wouter | President and Chief Executive | 24 | $100.0K | $4.38M | 2021-05-07 |
| Boyd Steven | Director, 10% Owner | 42 | $2.29M | $286.25M | 2020-06-29 |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | 12 | $203.2K | $7.61M | 2020-05-27 |
| Armistice Capital Master Fund Ltd. | 10% Owner | 24 | $67.3K | $26.43M | 2020-05-18 |
| Richard John P | Director | 3 | $7.6K | $0 | 2019-10-11 |
| Markham Richard J | Director | 2 | $0 | $0 | 2019-06-12 |
| VANLENT ANNE | Director | 2 | $0 | $0 | 2019-06-12 |
| COX GEOFFREY F | Director | 2 | $0 | $0 | 2019-06-12 |
| Harland John M | Chief Financial Officer | 6 | $0 | $0 | 2018-09-11 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2033-03-17 | 2023-03-21 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Bono Raquel C. | Director | A Award deriv | 2026-10-16 | 2026-10-20 | 157,400 | — | $0 | 157,400 | SEC↗ |
| Bono Raquel C. | Director | A Award | 2026-10-16 | 2026-10-20 | 78,800 | — | $0 | 78,800 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2026-07-16 | 2026-07-17 | 78,700 | — | $0 | 78,700 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2026-07-16 | 2026-07-17 | 78,700 | — | $0 | 78,700 | SEC↗ |
| HERON ELAINE J | Director | A Award deriv | 2026-07-16 | 2026-07-17 | 78,700 | — | $0 | 78,700 | SEC↗ |
| BREITMEYER JAMES B | Director | A Award deriv | 2026-07-16 | 2026-07-17 | 16,610 | — | $0 | 16,610 | SEC↗ |
| Finney Kevin | Director | A Award deriv | 2026-07-16 | 2026-07-20 | 78,700 | — | $0 | 78,700 | SEC↗ |
| Wheadon David E. | Director | A Award | 2026-07-16 | 2026-07-17 | 39,400 | — | $0 | 86,150 | SEC↗ |
| Watson W. Mark | Director | A Award | 2026-07-16 | 2026-07-17 | 39,400 | — | $0 | 173,525 | SEC↗ |
| HERON ELAINE J | Director | A Award | 2026-07-16 | 2026-07-17 | 39,400 | — | $0 | 135,966 | SEC↗ |
| BREITMEYER JAMES B | Director | A Award | 2026-07-16 | 2026-07-17 | 8,315 | — | $0 | 87,115 | SEC↗ |
| Finney Kevin | Director | A Award | 2026-07-16 | 2026-07-20 | 39,400 | — | $0 | 244,171 | SEC↗ |
| Watson W. Mark | Director | P Buy | 2026-05-22 | 2026-05-26 | 10,000 | $0.65 | $6.5K | 134,125 | SEC↗ |
| Grasman Jeroen Nicolaas | Chief Financial Officer | F Tax w/h | 2026-05-19 | 2026-05-21 | 31,395 | $0.61 | $19.2K | 545,605 | SEC↗ |
| BREITMEYER JAMES B | Director | A Award deriv | 2026-04-23 | 2026-05-01 | 157,400 | — | $0 | 157,400 | SEC↗ |
| BREITMEYER JAMES B | Director | A Award | 2026-04-23 | 2026-05-01 | 78,800 | — | $0 | 78,800 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2026-03-28 | 2026-03-31 | 3,292 | $0.65 | $2.1K | 924,177 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2026-03-28 | 2026-03-31 | 3,924 | $0.65 | $2.6K | 882,811 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2026-03-24 | 2026-03-26 | 36,418 | $0.69 | $25.1K | 886,735 | SEC↗ |
| Lo Steven | President, Chief Exec Office | F Tax w/h | 2026-03-24 | 2026-03-26 | 126,028 | $0.69 | $87.0K | 2,485,606 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2026-03-24 | 2026-03-26 | 30,551 | $0.69 | $21.1K | 927,469 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2026-03-24 | 2026-03-26 | 36,418 | $0.69 | $25.1K | 755,368 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2026-03-18 | 2026-03-20 | 8,072 | $0.63 | $5.1K | 923,153 | SEC↗ |
| Lo Steven | President, Chief Exec Office | F Tax w/h | 2026-03-18 | 2026-03-20 | 22,425 | $0.63 | $14.1K | 2,611,634 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2026-03-18 | 2026-03-20 | 6,772 | $0.63 | $4.3K | 958,020 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2026-03-18 | 2026-03-20 | 8,072 | $0.63 | $5.1K | 791,786 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2026-03-16 | 2026-03-18 | 225,000 | — | $0 | 225,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2026-03-16 | 2026-03-18 | 455,000 | — | $0 | 455,000 | SEC↗ |
| Grasman Jeroen Nicolaas | Chief Financial Officer | A Award deriv | 2026-03-16 | 2026-03-18 | 455,000 | — | $0 | 455,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2026-03-16 | 2026-03-18 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award deriv | 2026-03-16 | 2026-03-18 | 1,543,000 | — | $0 | 1,543,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award | 2026-03-16 | 2026-03-18 | 115,000 | — | $0 | 799,858 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2026-03-16 | 2026-03-18 | 227,000 | — | $0 | 964,792 | SEC↗ |
| Grasman Jeroen Nicolaas | Chief Financial Officer | A Award | 2026-03-16 | 2026-03-18 | 227,000 | — | $0 | 577,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2026-03-16 | 2026-03-18 | 200,000 | — | $0 | 931,225 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award | 2026-03-16 | 2026-03-18 | 846,500 | — | $0 | 2,634,059 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2026-02-02 | 2026-02-05 | 9,265 | $0.61 | $5.7K | 731,225 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2026-02-02 | 2026-02-05 | 9,265 | $0.61 | $5.7K | 684,858 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2026-02-02 | 2026-02-05 | 7,965 | $0.61 | $4.9K | 737,792 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award | 2025-12-04 | 2025-12-08 | 151,351 | — | $0 | 1,841,712 | SEC↗ |
| Lo Steven | President, Chief Exec Office | F Tax w/h | 2025-12-04 | 2025-12-08 | 54,153 | $0.37 | $20.0K | 1,787,559 | SEC↗ |
| HERON ELAINE J | Director | P Buy | 2025-11-17 | 2025-11-21 | 16,783 | $0.41 | $6.9K | 96,566 | SEC↗ |
| HERON ELAINE J | Director | P Buy | 2025-11-17 | 2025-11-21 | 23,217 | $0.39 | $9.1K | 79,783 | SEC↗ |
| Watson W. Mark | Director | P Buy | 2025-11-17 | 2025-12-05 | 5,000 | $0.41 | $2.0K | 124,125 | SEC↗ |
| Watson W. Mark | Director | P Buy | 2025-11-17 | 2025-12-05 | 15,000 | $0.41 | $6.2K | 119,125 | SEC↗ |
| Finney Kevin | Director | P Buy | 2025-08-15 | 2025-08-19 | 50,000 | $0.37 | $18.5K | 204,771 | SEC↗ |
| Finney Kevin | Director | P Buy | 2025-08-15 | 2025-08-19 | 50,000 | $0.35 | $17.5K | 154,771 | SEC↗ |
| Finney Kevin | Director | P Buy | 2025-07-30 | 2025-08-19 | 25,874 | $0.38 | $9.8K | 104,771 | SEC↗ |
| Watson W. Mark | Director | P Buy | 2025-07-29 | 2025-07-31 | 10,000 | $0.41 | $4.1K | 104,125 | SEC↗ |
| Finney Kevin | Director | P Buy | 2025-07-28 | 2025-08-19 | 20,000 | $0.40 | $8.0K | 78,897 | SEC↗ |
| Finney Kevin | Director | P Buy | 2025-07-25 | 2025-08-19 | 20,000 | $0.39 | $7.8K | 58,897 | SEC↗ |
| Finney Kevin | Director | P Buy | 2025-07-17 | 2025-08-19 | 794 | $0.38 | $302 | 38,897 | SEC↗ |
| Finney Michael J. | Director | A Award deriv | 2025-06-13 | 2025-06-16 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2025-06-13 | 2025-06-16 | 95,400 | — | $0 | 95,400 | SEC↗ |
| HERON ELAINE J | Director | A Award deriv | 2025-06-13 | 2025-06-16 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2025-06-13 | 2025-06-16 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Finney Kevin | Director | A Award deriv | 2025-06-13 | 2025-06-16 | 36,392 | — | $0 | 36,392 | SEC↗ |
| Finney Michael J. | Director | A Award | 2025-06-13 | 2025-06-16 | 16,000 | — | $0 | 702,840 | SEC↗ |
| Wheadon David E. | Director | A Award | 2025-06-13 | 2025-06-16 | 16,000 | — | $0 | 46,750 | SEC↗ |
| HERON ELAINE J | Director | A Award | 2025-06-13 | 2025-06-16 | 16,000 | — | $0 | 56,566 | SEC↗ |
| Watson W. Mark | Director | A Award | 2025-06-13 | 2025-06-16 | 16,000 | — | $0 | 94,125 | SEC↗ |
| Finney Kevin | Director | A Award | 2025-06-13 | 2025-06-16 | 6,103 | — | $0 | 38,103 | SEC↗ |
| Grasman Jeroen Nicolaas | Chief Financial Officer | A Award deriv | 2025-05-19 | 2025-05-20 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Lo Steven | President, Chief Exec Office | P Buy | 2025-05-19 | 2025-05-19 | 100,000 | $0.49 | $49.0K | 100,000 | SEC↗ |
| Grasman Jeroen Nicolaas | Chief Financial Officer | A Award | 2025-05-19 | 2025-05-20 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2025-03-28 | 2025-04-01 | 3,913 | $0.42 | $1.6K | 740,490 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2025-03-28 | 2025-04-01 | 3,292 | $0.42 | $1.4K | 745,757 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2025-03-24 | 2025-03-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2025-03-24 | 2025-03-26 | 610,000 | — | $0 | 610,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2025-03-24 | 2025-03-26 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2025-03-24 | 2025-03-26 | 610,000 | — | $0 | 610,000 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2025-03-24 | 2025-03-26 | 610,000 | — | $0 | 610,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2025-03-24 | 2025-03-26 | 610,000 | — | $0 | 610,000 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award deriv | 2025-03-24 | 2025-03-26 | 2,108,000 | — | $0 | 2,108,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award | 2025-03-24 | 2025-03-26 | 406,000 | — | $0 | 694,123 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2025-03-24 | 2025-03-26 | 406,000 | — | $0 | 749,049 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2025-03-24 | 2025-03-26 | 406,000 | — | $0 | 631,619 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2025-03-24 | 2025-03-26 | 406,000 | — | $0 | 744,403 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award | 2025-03-24 | 2025-03-26 | 1,405,000 | — | $0 | 1,632,638 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | F Tax w/h | 2025-03-18 | 2025-03-20 | 8,050 | $0.57 | $4.6K | 225,619 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2025-03-18 | 2025-03-20 | 8,050 | $0.57 | $4.6K | 338,403 | SEC↗ |
| Lo Steven | President, Chief Exec Office | F Tax w/h | 2025-03-18 | 2025-03-20 | 22,362 | $0.57 | $12.7K | 227,638 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2025-03-18 | 2025-03-20 | 6,772 | $0.57 | $3.9K | 343,049 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2025-03-18 | 2025-03-20 | 8,050 | $0.57 | $4.6K | 288,123 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2025-02-02 | 2025-02-04 | 9,242 | $0.68 | $6.3K | 261,464 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2025-02-02 | 2025-02-04 | 7,964 | $0.68 | $5.4K | 318,837 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2025-02-02 | 2025-02-04 | 9,242 | $0.68 | $6.3K | 346,453 | SEC↗ |
| Finney Kevin | Director | A Award deriv | 2025-01-28 | 2025-01-29 | 190,800 | — | $0 | 190,800 | SEC↗ |
| Finney Kevin | Director | A Award | 2025-01-28 | 2025-01-29 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | F Tax w/h | 2024-12-15 | 2024-12-17 | 6,132 | $0.59 | $3.6K | 233,669 | SEC↗ |
| Watson W. Mark | Director | P Buy | 2024-06-18 | 2024-06-20 | 20,000 | $0.68 | $13.6K | 78,125 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | F Tax w/h | 2024-06-12 | 2024-06-13 | 2,007 | $0.76 | $1.5K | 239,801 | SEC↗ |
| Yedid Robert A. | Director | A Award deriv | 2024-06-11 | 2024-06-12 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2024-06-11 | 2024-06-12 | 95,400 | — | $0 | 95,400 | SEC↗ |
| HERON ELAINE J | Director | A Award deriv | 2024-06-11 | 2024-06-12 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Finney Michael J. | Director | A Award deriv | 2024-06-11 | 2024-06-12 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2024-06-11 | 2024-06-12 | 95,400 | — | $0 | 95,400 | SEC↗ |
| Yedid Robert A. | Director | A Award | 2024-06-11 | 2024-06-12 | 16,000 | — | $0 | 34,490 | SEC↗ |
| Watson W. Mark | Director | A Award | 2024-06-11 | 2024-06-12 | 16,000 | — | $0 | 58,125 | SEC↗ |
| HERON ELAINE J | Director | A Award | 2024-06-11 | 2024-06-12 | 16,000 | — | $0 | 40,566 | SEC↗ |
| Finney Michael J. | Director | A Award | 2024-06-11 | 2024-06-12 | 16,000 | — | $0 | 686,840 | SEC↗ |
| Wheadon David E. | Director | A Award | 2024-06-11 | 2024-06-12 | 16,000 | — | $0 | 30,750 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2024-03-28 | 2024-04-01 | 3,292 | $1.30 | $4.3K | 326,801 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2024-03-28 | 2024-04-01 | 3,902 | $1.30 | $5.1K | 355,695 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award deriv | 2024-03-18 | 2024-03-20 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2024-03-18 | 2024-03-20 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2024-03-18 | 2024-03-20 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2024-03-18 | 2024-03-20 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2024-03-18 | 2024-03-20 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Lo Steven | President, Chief Exec Office | A Award | 2024-03-18 | 2024-03-20 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award | 2024-03-18 | 2024-03-20 | 90,000 | — | $0 | 270,706 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2024-03-18 | 2024-03-20 | 90,000 | — | $0 | 330,093 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2024-03-18 | 2024-03-20 | 90,000 | — | $0 | 241,808 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2024-03-18 | 2024-03-20 | 90,000 | — | $0 | 420,122 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2024-02-02 | 2024-03-20 | 9,220 | $1.20 | $11.1K | 180,706 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2024-02-02 | 2024-03-20 | 7,965 | $1.20 | $9.6K | 240,093 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2024-02-02 | 2024-03-20 | 9,220 | $1.20 | $11.1K | 330,122 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | F Tax w/h | 2023-12-15 | 2024-03-20 | 5,943 | $0.63 | $3.7K | 151,808 | SEC↗ |
| Berg Edward B | SVP, General Counsel | F Tax w/h | 2023-12-08 | 2024-03-20 | 33,752 | $0.71 | $24.0K | 189,926 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2023-12-08 | 2024-03-20 | 31,409 | $0.71 | $22.3K | 248,058 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | F Tax w/h | 2023-12-08 | 2024-03-20 | 35,151 | $0.71 | $25.0K | 157,751 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2023-12-08 | 2024-03-20 | 34,288 | $0.71 | $24.3K | 339,342 | SEC↗ |
| Finney Michael J. | Director | A Award deriv | 2023-06-26 | 2023-08-01 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2023-06-26 | 2023-08-01 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Yedid Robert A. | Director | A Award deriv | 2023-06-26 | 2023-08-01 | 44,224 | — | $0 | 44,224 | SEC↗ |
| HERON ELAINE J | Director | A Award deriv | 2023-06-26 | 2023-08-01 | 41,510 | — | $0 | 41,510 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2023-06-26 | 2023-08-01 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Finney Michael J. | Director | A Award | 2023-06-26 | 2023-08-01 | 7,375 | — | $0 | 670,840 | SEC↗ |
| Wheadon David E. | Director | A Award | 2023-06-26 | 2023-08-01 | 7,375 | — | $0 | 14,750 | SEC↗ |
| Yedid Robert A. | Director | A Award | 2023-06-26 | 2023-08-01 | 7,375 | — | $0 | 18,490 | SEC↗ |
| HERON ELAINE J | Director | A Award | 2023-06-26 | 2023-08-01 | 6,922 | — | $0 | 24,566 | SEC↗ |
| Watson W. Mark | Director | A Award | 2023-06-26 | 2023-08-01 | 7,375 | — | $0 | 42,125 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2023-06-12 | 2023-06-14 | 102,500 | — | $0 | 102,500 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2023-06-12 | 2023-06-14 | 22,500 | — | $0 | 192,902 | SEC↗ |
| Cummings James F. | Chief Medical Officer | F Tax w/h | 2023-03-28 | 2025-03-20 | 3,267 | $0.75 | $2.5K | 349,821 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | F Tax w/h | 2023-03-28 | 2024-03-20 | 3,683 | $0.75 | $2.8K | 373,630 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2023-03-17 | 2023-05-11 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2023-03-17 | 2023-05-11 | 45,000 | — | $0 | 113,750 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2023-03-17 | 2023-05-11 | 56,652 | — | $0 | 170,402 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2023-03-17 | 2023-03-21 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2023-03-17 | 2023-03-21 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2023-03-17 | 2023-03-21 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2023-03-17 | 2023-03-21 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2023-03-17 | 2023-03-21 | 205,000 | — | $0 | 205,000 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award deriv | 2023-03-17 | 2023-03-21 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award deriv | 2023-03-17 | 2023-03-21 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2023-03-17 | 2023-03-21 | 59,350 | — | $0 | 148,100 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2023-03-17 | 2023-03-21 | 90,000 | — | $0 | 238,100 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2023-03-17 | 2023-03-21 | 45,000 | — | $0 | 88,750 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2023-03-17 | 2023-03-21 | 90,000 | — | $0 | 316,788 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2023-03-17 | 2023-03-21 | 54,157 | — | $0 | 226,788 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2023-03-17 | 2023-03-21 | 45,000 | — | $0 | 172,631 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2023-03-17 | 2023-03-21 | 90,000 | — | $0 | 260,402 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2023-03-17 | 2023-03-21 | 56,652 | — | $0 | 170,402 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2023-03-17 | 2023-03-21 | 45,000 | — | $0 | 113,750 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award | 2023-03-17 | 2023-03-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award | 2023-03-17 | 2023-03-21 | 90,000 | — | $0 | 187,606 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award | 2023-03-17 | 2023-03-21 | 52,606 | — | $0 | 97,606 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award | 2023-03-17 | 2023-03-21 | 100,000 | — | $0 | 185,000 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award | 2023-03-17 | 2023-03-21 | 175,000 | — | $0 | 452,735 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award | 2023-03-17 | 2023-03-21 | 92,735 | — | $0 | 277,735 | SEC↗ |
| Watson W. Mark | Director | P Buy | 2022-12-28 | 2022-12-28 | 20,000 | $0.76 | $15.2K | 20,000 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award deriv | 2022-12-16 | 2022-12-30 | 412,500 | — | $0 | 412,500 | SEC↗ |
| Lee Phillip E | Chief Financial Officer | A Award | 2022-12-16 | 2022-12-30 | 68,750 | — | $0 | 68,750 | SEC↗ |
| HERON ELAINE J | Director | A Award deriv | 2022-08-25 | 2022-08-25 | 88,448 | — | $0 | 88,448 | SEC↗ |
| HERON ELAINE J | Director | A Award | 2022-08-25 | 2022-08-25 | 14,750 | — | $0 | 17,644 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2022-08-24 | 2022-08-26 | 4,000 | — | $0 | 11,115 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2022-08-24 | 2022-08-26 | 18,240 | — | $0 | 19,115 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2022-08-24 | 2022-08-26 | 4,000 | — | $0 | 15,115 | SEC↗ |
| Yedid Robert A. | Director | M Exercise deriv | 2022-08-19 | 2022-08-22 | 18,240 | — | $0 | 18,240 | SEC↗ |
| Yedid Robert A. | Director | M Exercise deriv | 2022-08-19 | 2022-08-22 | 8,000 | — | $0 | 57,700 | SEC↗ |
| Yedid Robert A. | Director | M Exercise | 2022-08-19 | 2022-08-22 | 8,000 | $2.39 | $19.1K | 37,355 | SEC↗ |
| Yedid Robert A. | Director | M Exercise | 2022-08-19 | 2022-08-22 | 18,240 | $0.31 | $5.7K | 29,355 | SEC↗ |
| Cherrington Julie M | Director | A Award deriv | 2022-08-04 | 2022-08-08 | 37,280 | — | $0 | 37,280 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2022-08-04 | 2022-08-08 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Finney Michael J. | Director | A Award deriv | 2022-08-04 | 2022-08-08 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2022-08-04 | 2022-08-08 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Yedid Robert A. | Director | A Award deriv | 2022-08-04 | 2022-08-08 | 44,224 | — | $0 | 44,224 | SEC↗ |
| Watson W. Mark | Director | A Award deriv | 2022-08-04 | 2022-08-08 | 88,448 | — | $0 | 88,448 | SEC↗ |
| Cherrington Julie M | Director | A Award | 2022-08-04 | 2022-08-08 | 6,217 | — | $0 | 6,217 | SEC↗ |
| Davis Todd C | Director | A Award | 2022-08-04 | 2022-08-08 | 7,375 | — | $0 | 125,905 | SEC↗ |
| Finney Michael J. | Director | A Award | 2022-08-04 | 2022-08-08 | 7,375 | — | $0 | 663,465 | SEC↗ |
| Wheadon David E. | Director | A Award | 2022-08-04 | 2022-08-08 | 7,375 | — | $0 | 7,375 | SEC↗ |
| Yedid Robert A. | Director | A Award | 2022-08-04 | 2022-08-08 | 7,375 | — | $0 | 11,115 | SEC↗ |
| Watson W. Mark | Director | A Award | 2022-08-04 | 2022-08-08 | 14,750 | — | $0 | 14,750 | SEC↗ |
| Ahmad Fuad | Interim CFO | P Buy | 2022-06-22 | 2022-06-23 | 5,000 | $3.22 | $16.1K | 5,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | M Exercise deriv | 2022-04-22 | 2022-04-25 | 40,000 | — | $0 | 84,061 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | M Exercise | 2022-04-22 | 2022-04-25 | 40,000 | $0.77 | $30.8K | 127,631 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2022-03-28 | 2022-03-30 | 262,500 | — | $0 | 262,500 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award deriv | 2022-03-28 | 2022-03-30 | 550,000 | — | $0 | 550,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award deriv | 2022-03-28 | 2022-03-30 | 262,500 | — | $0 | 262,500 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award | 2022-03-28 | 2022-03-30 | 43,750 | — | $0 | 87,631 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award | 2022-03-28 | 2022-03-30 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Cummings James F. | Chief Medical Officer | A Award | 2022-03-28 | 2022-03-30 | 43,750 | — | $0 | 43,750 | SEC↗ |
| Berg Edward B | SVP, General Counsel | A Award deriv | 2022-02-15 | 2022-02-22 | 285,000 | — | $0 | 285,000 | SEC↗ |
| Yedid Robert A. | Director | S Sale | 2022-01-10 | 2022-10-07 | 1,500 | $6.01 | $9.0K | 0 | SEC↗ |
| Davis Todd C | Director | G Gift | 2021-12-22 | 2021-12-23 | 1,470 | — | $0 | 118,530 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-11-30 | 2021-12-01 | 2,936 | — | $0 | 26,416 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-11-30 | 2021-12-01 | 666 | — | $0 | 1,667 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-11-30 | 2021-12-01 | 666 | $5.17 | $3.4K | 666 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-11-30 | 2021-12-01 | 2,936 | $0.77 | $2.3K | 3,602 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | S Sale | 2021-11-30 | 2021-12-01 | 3,602 | $8.00 | $28.8K | 0 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2021-10-12 | 2021-10-13 | 1,500 | — | $0 | 5,240 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2021-10-12 | 2021-10-13 | 1,500 | — | $0 | 6,740 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2021-10-12 | 2021-10-13 | 1,500 | — | $0 | 1,500 | SEC↗ |
| Yedid Robert A. | Director | G Gift | 2021-10-12 | 2021-10-13 | 1,500 | — | $0 | 3,740 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-09-10 | 2021-09-13 | 1,467 | — | $0 | 29,352 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-09-10 | 2021-09-13 | 334 | — | $0 | 2,333 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-09-10 | 2021-09-13 | 334 | $5.17 | $1.7K | 334 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | S Sale | 2021-09-10 | 2021-09-13 | 1,801 | $9.10 | $16.4K | 0 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-09-10 | 2021-09-13 | 1,467 | $0.77 | $1.1K | 1,801 | SEC↗ |
| Cherrington Julie M | Director | A Award deriv | 2021-08-20 | 2021-08-23 | 65,700 | — | $0 | 65,700 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-08-10 | 2021-08-11 | 333 | — | $0 | 2,667 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-08-10 | 2021-08-11 | 1,468 | — | $0 | 30,819 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-08-10 | 2021-08-11 | 333 | $5.17 | $1.7K | 333 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-08-10 | 2021-08-11 | 1,468 | $0.77 | $1.1K | 1,801 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | S Sale | 2021-08-10 | 2021-08-11 | 1,801 | $10.00 | $18.0K | 0 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | S Sale | 2021-08-10 | 2021-08-11 | 4,172 | $10.20 | $42.6K | 43,881 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | S Sale | 2021-08-10 | 2021-08-11 | 5,828 | $10.20 | $59.4K | 51,465 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-07-19 | 2021-07-21 | 333 | — | $0 | 3,000 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-07-19 | 2021-07-21 | 1,467 | — | $0 | 32,287 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-07-19 | 2021-07-21 | 1,467 | $0.77 | $1.1K | 1,800 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | S Sale | 2021-07-19 | 2021-07-21 | 1,800 | $8.00 | $14.4K | 0 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-07-19 | 2021-07-21 | 333 | $5.17 | $1.7K | 333 | SEC↗ |
| Finney Michael J. | Director | X Exercise deriv | 2021-06-18 | 2021-06-21 | 181,818 | — | $0 | 0 | SEC↗ |
| Finney Michael J. | Director | M Exercise deriv | 2021-06-18 | 2021-06-21 | 12,700 | — | $0 | 0 | SEC↗ |
| Finney Michael J. | Director | M Exercise deriv | 2021-06-18 | 2021-06-21 | 9,000 | — | $0 | 0 | SEC↗ |
| Finney Michael J. | Director | X Exercise | 2021-06-18 | 2021-06-21 | 181,818 | $1.10 | $200.0K | 656,090 | SEC↗ |
| Finney Michael J. | Director | M Exercise | 2021-06-18 | 2021-06-21 | 12,700 | $0.68 | $8.6K | 474,272 | SEC↗ |
| Finney Michael J. | Director | M Exercise | 2021-06-18 | 2021-06-21 | 9,000 | $0.68 | $6.1K | 461,572 | SEC↗ |
| Floroiu Cezar Andrei | President, Chief Exec Office | A Award deriv | 2021-06-16 | 2021-06-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Tucker Sean | SVP, Chief Scientific Office | A Award deriv | 2021-06-16 | 2021-06-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | A Award deriv | 2021-06-16 | 2021-06-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 15,097 | — | $0 | 15,097 | SEC↗ |
| Finney Michael J. | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 15,097 | — | $0 | 15,097 | SEC↗ |
| WILSON KAREN J | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 15,097 | — | $0 | 15,097 | SEC↗ |
| Yedid Robert A. | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 15,097 | — | $0 | 15,097 | SEC↗ |
| Wheadon David E. | Director | A Award deriv | 2021-06-16 | 2021-06-17 | 65,700 | — | $0 | 65,700 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-06-11 | 2021-06-14 | 1,468 | — | $0 | 33,754 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-06-11 | 2021-06-14 | 334 | — | $0 | 3,333 | SEC↗ |
| Yedid Robert A. | Director | M Exercise deriv | 2021-06-11 | 2021-06-14 | 18,240 | — | $0 | 36,480 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-06-11 | 2021-06-14 | 334 | $5.17 | $1.7K | 334 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | S Sale | 2021-06-11 | 2021-06-14 | 1,802 | $8.00 | $14.4K | 0 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-06-11 | 2021-06-14 | 1,468 | $0.77 | $1.1K | 1,802 | SEC↗ |
| Yedid Robert A. | Director | M Exercise | 2021-06-11 | 2021-06-14 | 18,240 | $0.31 | $5.7K | 18,240 | SEC↗ |
| Yedid Robert A. | Director | S Sale | 2021-06-11 | 2021-06-14 | 10,000 | $8.61 | $86.1K | 8,240 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-06-09 | 2021-06-11 | 35,222 | — | $0 | 35,222 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise deriv | 2021-06-09 | 2021-06-11 | 12,333 | — | $0 | 3,667 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-06-09 | 2021-06-11 | 12,333 | $5.17 | $63.8K | 12,333 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | M Exercise | 2021-06-09 | 2021-06-11 | 35,222 | $0.77 | $27.1K | 47,555 | SEC↗ |
| Echerd Margaret | SVP, Principal Accntng Offic | S Sale | 2021-06-09 | 2021-06-11 | 47,555 | $8.00 | $380.4K | 0 | SEC↗ |
| Latour Wouter | Director | M Exercise deriv | 2021-05-07 | 2021-05-10 | 100,000 | — | $0 | 700,000 | SEC↗ |
| Latour Wouter | Director | M Exercise | 2021-05-07 | 2021-05-10 | 100,000 | $1.70 | $170.0K | 100,000 | SEC↗ |
| Latour Wouter | Director | S Sale | 2021-05-07 | 2021-05-10 | 100,000 | $7.13 | $713.0K | 0 | SEC↗ |
| Latour Wouter | Director | M Exercise deriv | 2021-05-06 | 2021-05-10 | 100,000 | — | $0 | 800,000 | SEC↗ |
| Latour Wouter | Director | M Exercise | 2021-05-06 | 2021-05-10 | 100,000 | $1.70 | $170.0K | 100,000 | SEC↗ |
| Latour Wouter | Director | S Sale | 2021-05-06 | 2021-05-10 | 100,000 | $6.54 | $654.0K | 0 | SEC↗ |
| Tucker Sean | Chief Scientific Officer | M Exercise deriv | 2021-03-16 | 2021-03-18 | 1,006 | — | $0 | 0 | SEC↗ |
| Tucker Sean | Chief Scientific Officer | M Exercise | 2021-03-16 | 2021-03-18 | 1,006 | $6.49 | $6.5K | 48,053 | SEC↗ |
| Latour Wouter | Director | M Exercise deriv | 2021-03-04 | 2021-03-05 | 150,000 | — | $0 | 213,261 | SEC↗ |
| Latour Wouter | Director | S Sale | 2021-03-04 | 2021-03-05 | 150,000 | $6.04 | $906.0K | 0 | SEC↗ |
| Latour Wouter | Director | M Exercise | 2021-03-04 | 2021-03-05 | 150,000 | $0.77 | $115.5K | 150,000 | SEC↗ |
| Latour Wouter | Director | S Sale | 2020-11-23 | 2020-11-23 | 333,334 | $6.32 | $2.11M | 0 | SEC↗ |
| WILSON KAREN J | Director | A Award deriv | 2020-08-25 | 2020-08-27 | 65,700 | — | $0 | 65,700 | SEC↗ |
| Tucker Sean | Chief Scientific Officer | M Exercise deriv | 2020-08-13 | 2020-08-14 | 4,026 | — | $0 | 0 | SEC↗ |
| Tucker Sean | Chief Scientific Officer | M Exercise | 2020-08-13 | 2020-08-14 | 4,026 | $6.49 | $26.1K | 51,679 | SEC↗ |
| Latour Wouter | Director | X Exercise deriv | 2020-08-12 | 2020-08-12 | 166,667 | $0.30 | $50.0K | 0 | SEC↗ |
| Latour Wouter | Director | X Exercise | 2020-08-12 | 2020-08-12 | 166,667 | $0.30 | $50.0K | 333,334 | SEC↗ |
| Boyd Steven | Director | X Exercise deriv | 2020-06-29 | 2020-06-30 | 0 | — | $0 | 0 | SEC↗ |
| Boyd Steven | Director | X Exercise deriv | 2020-06-29 | 2020-06-30 | 4,090,909 | — | $0 | 0 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-29 | 2020-06-30 | 0 | — | $0 | 145,523 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-29 | 2020-06-30 | 9,385,386 | $8.29 | $77.80M | 145,523 | SEC↗ |
| Boyd Steven | Director | X Exercise | 2020-06-29 | 2020-06-30 | 0 | — | $0 | 9,530,909 | SEC↗ |
| Boyd Steven | Director | X Exercise | 2020-06-29 | 2020-06-30 | 4,090,909 | $1.10 | $4.50M | 9,530,909 | SEC↗ |
| Boyd Steven | Director | X Exercise deriv | 2020-06-26 | 2020-06-30 | 16,666,667 | — | $0 | 0 | SEC↗ |
| Boyd Steven | Director | X Exercise deriv | 2020-06-26 | 2020-06-30 | 0 | — | $0 | 0 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-26 | 2020-06-30 | 0 | — | $0 | 5,440,000 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-26 | 2020-06-30 | 18,226,667 | $10.38 | $189.19M | 5,440,000 | SEC↗ |
| Boyd Steven | Director | X Exercise | 2020-06-26 | 2020-06-30 | 0 | — | $0 | 23,666,667 | SEC↗ |
| Boyd Steven | Director | X Exercise | 2020-06-26 | 2020-06-30 | 16,666,667 | $0.30 | $5.00M | 23,666,667 | SEC↗ |
| Floroiu Cezar Andrei | Chief Executive Officer | A Award deriv | 2020-06-15 | 2020-06-17 | 845,280 | — | $0 | 845,280 | SEC↗ |
| Floroiu Cezar Andrei | Chief Executive Officer | A Award deriv | 2020-06-15 | 2020-06-17 | 900,000 | — | $0 | 900,000 | SEC↗ |
| Latour Wouter | President and Chief Executiv | A Award deriv | 2020-06-08 | 2020-06-09 | 900,000 | — | $0 | 900,000 | SEC↗ |
| Tucker Sean | Chief Scientific Officer | A Award deriv | 2020-06-08 | 2020-06-09 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Echerd Margaret | VP, Corporate Controller, PA | A Award deriv | 2020-06-08 | 2020-06-09 | 315,000 | — | $0 | 315,000 | SEC↗ |
| Floroiu Cezar Andrei | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 54,720 | — | $0 | 54,720 | SEC↗ |
| Davis Todd C | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 65,700 | — | $0 | 65,700 | SEC↗ |
| Finney Michael J. | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 65,700 | — | $0 | 65,700 | SEC↗ |
| Yedid Robert A. | Director | A Award deriv | 2020-06-08 | 2020-06-09 | 65,700 | — | $0 | 65,700 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-03 | 2020-06-03 | 0 | — | $0 | 7,000,000 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-03 | 2020-06-03 | 400,000 | $2.77 | $1.11M | 7,000,000 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-02 | 2020-06-03 | 0 | — | $0 | 7,400,000 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-02 | 2020-06-03 | 800,000 | $2.75 | $2.20M | 7,400,000 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-01 | 2020-06-03 | 200,000 | $2.74 | $548.0K | 8,200,000 | SEC↗ |
| Boyd Steven | Director | S Sale | 2020-06-01 | 2020-06-03 | 0 | — | $0 | 8,200,000 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | S Sale | 2020-05-27 | 2020-05-29 | 0 | — | $0 | 8,400,000 | SEC↗ |
| ARMISTICE CAPITAL, LLC | Director, 10% Owner | S Sale | 2020-05-27 | 2020-05-29 | 200,000 | $2.61 | $522.0K | 8,400,000 | SEC↗ |